MXPA03009411A - COMPOSICIoN FARMACeUTICA SUMINISTRABLE ORALMENTE QUE COMPRENDE UN MEDICAMENTO DE POCA HIDROSUBILIDAD (INHIBIDOR DE COX-2), UN SOLVENTE, UN ACIDO GRASO Y UNA AMINA ORGANICA. - Google Patents

COMPOSICIoN FARMACeUTICA SUMINISTRABLE ORALMENTE QUE COMPRENDE UN MEDICAMENTO DE POCA HIDROSUBILIDAD (INHIBIDOR DE COX-2), UN SOLVENTE, UN ACIDO GRASO Y UNA AMINA ORGANICA.

Info

Publication number
MXPA03009411A
MXPA03009411A MXPA03009411A MXPA03009411A MXPA03009411A MX PA03009411 A MXPA03009411 A MX PA03009411A MX PA03009411 A MXPA03009411 A MX PA03009411A MX PA03009411 A MXPA03009411 A MX PA03009411A MX PA03009411 A MXPA03009411 A MX PA03009411A
Authority
MX
Mexico
Prior art keywords
cox
inhibitor
drug
solvent
pharmaceutical composition
Prior art date
Application number
MXPA03009411A
Other languages
English (en)
Spanish (es)
Inventor
Karim Aziz
Original Assignee
Pharmacia Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Corp filed Critical Pharmacia Corp
Publication of MXPA03009411A publication Critical patent/MXPA03009411A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Dispersion Chemistry (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MXPA03009411A 2001-04-17 2002-04-12 COMPOSICIoN FARMACeUTICA SUMINISTRABLE ORALMENTE QUE COMPRENDE UN MEDICAMENTO DE POCA HIDROSUBILIDAD (INHIBIDOR DE COX-2), UN SOLVENTE, UN ACIDO GRASO Y UNA AMINA ORGANICA. MXPA03009411A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US28438101P 2001-04-17 2001-04-17
US32695201P 2001-10-04 2001-10-04
PCT/US2002/011689 WO2002083177A1 (en) 2001-04-17 2002-04-12 Orally deliverable pharmaceutical composition comprising a drug of low water solubility (cox-2 inhibitor), a solvent, a fatty acid and an organic amine

Publications (1)

Publication Number Publication Date
MXPA03009411A true MXPA03009411A (es) 2004-01-29

Family

ID=26962574

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03009411A MXPA03009411A (es) 2001-04-17 2002-04-12 COMPOSICIoN FARMACeUTICA SUMINISTRABLE ORALMENTE QUE COMPRENDE UN MEDICAMENTO DE POCA HIDROSUBILIDAD (INHIBIDOR DE COX-2), UN SOLVENTE, UN ACIDO GRASO Y UNA AMINA ORGANICA.

Country Status (18)

Country Link
US (1) US20030105141A1 (enExample)
EP (1) EP1379279A1 (enExample)
JP (1) JP2004530669A (enExample)
KR (1) KR20040018355A (enExample)
CN (1) CN1516601A (enExample)
AR (1) AR033221A1 (enExample)
AU (1) AU2002305175B2 (enExample)
BR (1) BR0208994A (enExample)
CA (1) CA2444220A1 (enExample)
CZ (1) CZ20032792A3 (enExample)
EA (1) EA008103B1 (enExample)
IL (1) IL158201A0 (enExample)
MX (1) MXPA03009411A (enExample)
NO (1) NO20034629L (enExample)
NZ (1) NZ528741A (enExample)
PE (1) PE20021145A1 (enExample)
PL (1) PL364524A1 (enExample)
WO (1) WO2002083177A1 (enExample)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7115565B2 (en) * 2001-01-18 2006-10-03 Pharmacia & Upjohn Company Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability
EP1344523A1 (en) * 2002-03-11 2003-09-17 Warner-Lambert Company Ibuprofen solution for hard gelatin capsules
IL164163A0 (en) * 2002-04-09 2005-12-18 Pharmacia Corp Process for preparing a finely self-emulsifiable pharmaceutical composition
US20060141470A1 (en) * 2003-02-14 2006-06-29 Kalayoglu Murat V Chlamydia pneumoniae associated chronic intraocular disorders and treatment thereof
EP1653931A2 (en) * 2003-07-17 2006-05-10 Banner Pharmacaps, Inc. Controlled release preparations
EP1510206A1 (en) * 2003-08-29 2005-03-02 Novagali Pharma SA Self-nanoemulsifying oily formulation for the administration of poorly water-soluble drugs
US20060002989A1 (en) * 2004-06-10 2006-01-05 Ahmed Salah U Formulations of sumatriptan for absorption across biological membranes, and methods of making and using the same
CN101142198B (zh) * 2005-02-17 2012-10-31 辛塔制药公司 用于治疗疾病的异*唑坎布雷它斯丁衍生物
CN101360485B (zh) * 2005-10-26 2013-04-17 班纳制药公司 作为胶囊填充物的基于亲水性载体的双重控释基质系统
JP5406529B2 (ja) 2005-10-26 2014-02-05 バナー ファーマキャプス， インコーポレイテッド カプセル充墳物としての親油性ベヒクルに基づく二重制御された放出マトリクスシステム
WO2009040776A1 (en) * 2007-09-27 2009-04-02 Wockhardt Research Centre Self-emulsifying pharmaceutical compositions of rhein or diacerein
PL2367542T3 (pl) * 2008-12-03 2014-05-30 Astellas Deutschland Gmbh Doustne formy dawkowania bendamustyny
JP5951489B2 (ja) 2009-10-16 2016-07-13 グラクソスミスクライン・リミテッド・ライアビリティ・カンパニーＧｌａｘｏＳｍｉｔｈＫｌｉｎｅ ＬＬＣ 組成物
JO3659B1 (ar) 2010-06-02 2020-08-27 Astellas Deutschland Gmbh أشكال جرعات بينداموستين عن طريق الفم وإستخداماته العلاجية
WO2011151087A1 (en) * 2010-06-02 2011-12-08 Astellas Deutschland Gmbh Oral dosage forms of bendamustine
EP2392319A1 (en) * 2010-06-04 2011-12-07 Laboratorios Del. Dr. Esteve, S.A. Pharmaceutical compositions of co-crystals of tramadol and coxibs
US9119826B2 (en) 2011-02-16 2015-09-01 Pivotal Therapeutics, Inc. Omega 3 fatty acid for use as a prescription medical food and omega 3 fatty acid diagniostic assay for the dietary management of cardiovascular patients with cardiovascular disease (CVD) who are deficient in blood EPA and DHA levels
US8951514B2 (en) 2011-02-16 2015-02-10 Pivotal Therapeutics Inc. Statin and omega 3 fatty acids for reduction of apolipoprotein-B levels
US8952000B2 (en) 2011-02-16 2015-02-10 Pivotal Therapeutics Inc. Cholesterol absorption inhibitor and omega 3 fatty acids for the reduction of cholesterol and for the prevention or reduction of cardiovascular, cardiac and vascular events
RU2630617C2 (ru) 2011-10-18 2017-09-11 Аскат Инк. Фармацевтическая композиция
PL3795141T3 (pl) * 2013-01-14 2025-11-12 Infirst Healthcare Limited Kompozycje w postaci roztworu stałego
BR112015015870B1 (pt) * 2013-02-04 2022-09-27 Infirst Healthcare Limited Uso de uma composição farmacêutica
CN109953954A (zh) 2013-08-27 2019-07-02 V·沃道里斯 苯达莫司汀医药组合物
EP3481923A4 (en) 2016-07-05 2019-12-18 Golden Renewable Energy, LLC SYSTEM AND METHOD FOR CONVERTING WASTE PLASTIC INTO FUEL
US12213510B2 (en) 2019-09-11 2025-02-04 Nicoventures Trading Limited Pouched products with enhanced flavor stability
CN113750043A (zh) * 2021-09-18 2021-12-07 山东省药学科学院 一种塞来昔布自乳化口服液及其制备方法
WO2024142089A1 (en) * 2022-12-27 2024-07-04 Cipla Limited Injectable compositions of celecoxib

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE233245T1 (de) * 1993-11-30 2003-03-15 Searle & Co Substituierte pyrazolyl-benzolsulfonamide und ihre verwendung als cyclooxygenaseii inhibitoren
US5571536A (en) * 1995-02-06 1996-11-05 Nano Systems L.L.C. Formulations of compounds as nanoparticulate dispersions in digestible oils or fatty acids
US5733909A (en) * 1996-02-01 1998-03-31 Merck Frosst Canada, Inc. Diphenyl stilbenes as prodrugs to COX-2 inhibitors
WO1999009988A1 (en) * 1997-08-27 1999-03-04 Hexal Ag New pharmaceutical compositions of meloxicam with improved solubility and bioavailability
US6025353A (en) * 1997-11-19 2000-02-15 G.D. Searle & Co. Method of using cyclooxygenase-2 inhibitors as anti-angiogenic agents
SA99191255B1 (ar) * 1998-11-30 2006-11-25 جي دي سيرل اند كو مركبات سيليكوكسيب celecoxib
MY120279A (en) * 2000-05-26 2005-09-30 Pharmacia Corp Use of a celecoxib composition for fast pain relief
US20020077328A1 (en) * 2000-07-13 2002-06-20 Fred Hassan Selective cyclooxygenase-2 inhibitors and vasomodulator compounds for generalized pain and headache pain

Also Published As

Publication number Publication date
EP1379279A1 (en) 2004-01-14
AU2002305175B2 (en) 2007-07-12
WO2002083177A1 (en) 2002-10-24
NZ528741A (en) 2005-09-30
PE20021145A1 (es) 2003-01-16
CA2444220A1 (en) 2002-10-24
CN1516601A (zh) 2004-07-28
NO20034629D0 (no) 2003-10-16
NO20034629L (no) 2003-12-10
US20030105141A1 (en) 2003-06-05
CZ20032792A3 (cs) 2004-04-14
KR20040018355A (ko) 2004-03-03
JP2004530669A (ja) 2004-10-07
EA200301019A1 (ru) 2004-06-24
IL158201A0 (en) 2004-05-12
BR0208994A (pt) 2004-04-27
AR033221A1 (es) 2003-12-10
PL364524A1 (en) 2004-12-13
EA008103B1 (ru) 2007-04-27

Similar Documents

Publication Publication Date Title
MXPA03009411A (es) COMPOSICIoN FARMACeUTICA SUMINISTRABLE ORALMENTE QUE COMPRENDE UN MEDICAMENTO DE POCA HIDROSUBILIDAD (INHIBIDOR DE COX-2), UN SOLVENTE, UN ACIDO GRASO Y UNA AMINA ORGANICA.
IL216686A (en) Ritonavir-containing drug solution and organic solvent containing a mixture of long fatty acids and water
CY2013023I1 (el) Φαρμακο για την υπερδραστηρια ουροδοχο κυστη περιλαμβανον παραγωγο ανιλιδιου οξικου οξεος ως το ενεργο συστατικο
IL162118A0 (en) Pharmaceutical compositions containing an orally active taxane derivative
MXPA03009410A (es) COMPOSICIoN FARMACEUTICA QUE SE ADMINISTRA ORALMENTE QUE COMPRENDE UN COMPUESTO ACTIVO QUE TIENE UN GRUPO AMINOSULFONILO (INHIBIDOR COX-2) UN POLIETILEN GLICOL Y UN ANTIOXIDANTE DEPURADOR DE RADICALES LIBRES.
AU2002350719A1 (en) Pharmaceutical compositions comprising a basic respectively acidic drug compound, a surfactant and a physiologically tolerable water-soluble acid respectively base
NO20040564L (no) Karboksylsyrederivatforbindelser og legemidler omfattende disse forbindelser som den aktive bestanddel
NO2014005I1 (no) olodaterol, syreaddisjonssalter og farmakologisk akseptable syrer derav
EP1246608A4 (en) PHARMACEUTICAL PREPARATIONS FOR THE ADMINISTRATION OF ACTIVE SUBSTANCES WITH LOW WATER SOLUBILITY
NO20040178L (no) Farmasoytisk formulering innebefattende en protonpumpeinhibitor og syrenoytraliserende midler
NL300343I1 (nl) 6-alfa, 9-alfa-difluor-17-alfa-(2-furanylcarboxyl)oxy-11-beta-hydroxy-16-alfa-methyl-3-oxo-androst-1, 4-dieen-17-carbothionzuur-s-fluormethylester alseen ontstekingremmend middel
AU2001298061A1 (en) Microencapsulation of drugs by solvent exchange
UY27273A1 (es) Solución oral de arilpiprazol
NO331093B1 (no) Somatostatinanaloger, fremgangsmåte for fremstilling, farmasøytisk sammensetning og anvendelse derav.
WO2003086392A3 (en) Process for preparing a finely self-emulsifiable pharmaceutical composition
WO2002008217A3 (en) COUMARIN DERIVATIVES USEFUL AS TNFα INHIBITORS
NO20040356L (no) Indaneddiksyrederivater og deres andvendelse som farmasoytiske midler, intermediater og fremgangsmate for fremstilling.
CA2515293A1 (en) Eicosapentaenoic acid for use in improving prognosis in the treatment of subarachnoid hemorrhage
WO2004009583A3 (en) Benzimidazole derivatives and their use as prodrugs of proton pump inhibitor
AR079399A2 (es) Procedimientos para preparar bifenazato
AU2001234089A1 (en) Cancer remedy comprising anthranilic acid derivative as active ingredient
AU3408901A (en) Cancer remedy comprising anthranilic acid derivative as active ingredient
HUP0303694A3 (en) Aza-amino acid derivatives and pharmaceutical
AU2003260239A1 (en) Solid dosage forms for rapid dissolution of poorly soluble drugs
GB2398005B (en) Orally administrable pharmaceutical formulation

Legal Events

Date Code Title Description
FA Abandonment or withdrawal